These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 17635112)

  • 1. Regulation of matrix turnover: fibroblasts, forces, factors and fibrosis.
    Laurent GJ; Chambers RC; Hill MR; McAnulty RJ
    Biochem Soc Trans; 2007 Aug; 35(Pt 4):647-51. PubMed ID: 17635112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct contribution of epithelium to organ fibrosis: epithelial-mesenchymal transition.
    Guarino M; Tosoni A; Nebuloni M
    Hum Pathol; 2009 Oct; 40(10):1365-76. PubMed ID: 19695676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trichostatin A prevents the accumulation of extracellular matrix in a mouse model of bleomycin-induced skin fibrosis.
    Huber LC; Distler JH; Moritz F; Hemmatazad H; Hauser T; Michel BA; Gay RE; Matucci-Cerinic M; Gay S; Distler O; Jüngel A
    Arthritis Rheum; 2007 Aug; 56(8):2755-64. PubMed ID: 17665426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progression in chronic kidney disease.
    Eddy AA
    Adv Chronic Kidney Dis; 2005 Oct; 12(4):353-65. PubMed ID: 16198274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The renal cortical fibroblast in renal tubulointerstitial fibrosis.
    Qi W; Chen X; Poronnik P; Pollock CA
    Int J Biochem Cell Biol; 2006 Jan; 38(1):1-5. PubMed ID: 16230044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic fibrosis and cirrhosis: the (myo)fibroblastic cell subpopulations involved.
    Guyot C; Lepreux S; Combe C; Doudnikoff E; Bioulac-Sage P; Balabaud C; Desmoulière A
    Int J Biochem Cell Biol; 2006 Feb; 38(2):135-51. PubMed ID: 16257564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular and molecular events leading to renal tubulointerstitial fibrosis.
    Razzaque MS; Taguchi T
    Med Electron Microsc; 2002 Jun; 35(2):68-80. PubMed ID: 12181648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Escape from the matrix: multiple mechanisms for fibroblast activation in pulmonary fibrosis.
    Laurent GJ; McAnulty RJ; Hill M; Chambers R
    Proc Am Thorac Soc; 2008 Apr; 5(3):311-5. PubMed ID: 18403325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibroblast autophagy in fibrotic disorders.
    Del Principe D; Lista P; Malorni W; Giammarioli AM
    J Pathol; 2013 Jan; 229(2):208-20. PubMed ID: 23018629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The definition of fibrogenic processes in fibroblastic foci of idiopathic pulmonary fibrosis based on morphometric quantification of extracellular matrices.
    Yamashita M; Yamauchi K; Chiba R; Iwama N; Date F; Shibata N; Kumagai H; Risteli J; Sato S; Takahashi T; Ono M
    Hum Pathol; 2009 Sep; 40(9):1278-87. PubMed ID: 19386353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Molecular and cellular mechanisms of organ fibrosis].
    Oka T; Komuro I
    Nihon Rinsho; 2012 Sep; 70(9):1510-6. PubMed ID: 23012796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myofibroblasts work best under stress.
    Wipff PJ; Hinz B
    J Bodyw Mov Ther; 2009 Apr; 13(2):121-7. PubMed ID: 19329048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Into the matrix: targeting fibroblasts in pulmonary fibrosis.
    Sivakumar P; Ntolios P; Jenkins G; Laurent G
    Curr Opin Pulm Med; 2012 Sep; 18(5):462-9. PubMed ID: 22847104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Fibrocytes and fibroblasts. Definition and significance in wound healing and fibrotic diseases of the skin].
    Krieg T; Braun-Falco O
    Z Hautkr; 1989 Sep; 64(9):775-6, 779-81. PubMed ID: 2683440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibroblast differentiation in wound healing and fibrosis.
    Darby IA; Hewitson TD
    Int Rev Cytol; 2007; 257():143-79. PubMed ID: 17280897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors controlling matrix turnover in health and disease.
    Buttle DJ
    Biochem Soc Trans; 2007 Aug; 35(Pt 4):643-6. PubMed ID: 17635111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does transformation of microvascular endothelial cells into myofibroblasts play a key role in the etiology and pathology of fibrotic disease?
    Karasek MA
    Med Hypotheses; 2007; 68(3):650-5. PubMed ID: 17045756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myostatin promotes a fibrotic phenotypic switch in multipotent C3H 10T1/2 cells without affecting their differentiation into myofibroblasts.
    Artaza JN; Singh R; Ferrini MG; Braga M; Tsao J; Gonzalez-Cadavid NF
    J Endocrinol; 2008 Feb; 196(2):235-49. PubMed ID: 18252947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular and molecular pathology of HTS: basis for treatment.
    Armour A; Scott PG; Tredget EE
    Wound Repair Regen; 2007; 15 Suppl 1():S6-17. PubMed ID: 17727469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Connective tissue growth factor: growth factor, matricellular organizer, fibrotic biomarker or molecular target for anti-fibrotic therapy in SSc?
    Abraham D
    Rheumatology (Oxford); 2008 Oct; 47 Suppl 5():v8-9. PubMed ID: 18784153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.